KCNQ5 (Q9NR82) variants and mutations
KCNQ5 (also known as Q9NR82) is a human protein-coding gene encoding a potassium voltage-gated channel subfamily KQT member 5 protein. Its slowly activating potassium current helps stabilize membrane excitability in neurons and smooth muscle. Pathogenic variants can cause neurodevelopmental disorders with intellectual disability and epilepsy, with both gain- and loss-of-function mechanisms reported. This analysis covers 1,571 KCNQ5 variants and mutations. Of these, 69% have computational variant effect predictions. Disease context includes intellectual disability, autosomal dominant 46, multiple sclerosis, and Lambert-Eaton myasthenic syndrome. Example KCNQ5 variants include M1T, P2R, and P2S.
Variant analysis overview
- Gene: KCNQ5
- Protein: Q9NR82
- UniProt accession: Q9NR82
- Organism: Homo sapiens
- Variants analyzed: 1571
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 1,172 unspecified-consequence records; 243 missense variants; 117 synonymous variants; 20 frameshift variants; 8 stop-gained variants; 7 in-frame deletions; 3 in-frame insertions; 1 splice-region variants
- Prediction scores: 1,088 variants have prediction scores (69% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: intellectual disability, autosomal dominant 46, multiple sclerosis, Lambert-Eaton myasthenic syndrome, myasthenia gravis, epilepsy, congenital myasthenic syndrome, Congenital myasthenic syndromes, Seizure, Abnormality of the skeletal system, Muscle weakness, schizophrenia, Intellectual disability.
Protein structure and variant hotspots
- Protein features: 6 transmembrane segments; 3 binding sites; 3 post-translational modification sites.
- Structural context: 154 variants have structural context.
- PTM context: 5 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable KCNQ5 variants
Examples include M1T, P2R, P2S, P2T, P2H, P2L, P2P, R3G. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1T (p.Met1Thr), rs2481564750, ClinGen CA364823946, ClinVar RCV003688778, Pathogenic, not provided
- P2R (p.Pro2Arg), TOPMed rs2098915492
- P2S (p.Pro2Ser), gnomAD 6-72622193-C-T, REVEL 0.58, CADD 26.70
- P2T (p.Pro2Thr), gnomAD 6-72622193-C-A, REVEL 0.61, CADD 26.10
- P2H (p.Pro2His), gnomAD 6-72622194-C-A, REVEL 0.58, CADD 24.10
- P2L (p.Pro2Leu), gnomAD 6-72622194-C-T, REVEL 0.71, CADD 27.50
- P2P (p.Pro2Pro), gnomAD 6-72622195-C-T, CADD 16.10
- R3G (p.Arg3Gly), 1000Genomes rs549110435, TOPMed rs549110435, gnomAD rs549110435, Likely benign
- R3S (p.Arg3Ser), rs549110435, ClinGen CA141452098, ClinVar RCV001200473, ClinVar RCV001252271, REVEL 0.67, CADD 27.50, Conflicting interpretations, Intellectual disability, autosomal dominant 46; not provided; Inborn genetic dis
- R3C (p.Arg3Cys), 1000Genomes rs549110435, TOPMed rs549110435, gnomAD rs549110435, REVEL 0.72, CADD 32.00, Likely benign
- R3L (p.Arg3Leu), rs1446827633, ClinGen CA364823961, ClinVar RCV003845254, ClinVar RCV004366917, REVEL 0.74, CADD 29.50, Conflicting interpretations, Intellectual disability, autosomal dominant 46; Inborn genetic diseases; not pro
- R3P (p.Arg3Pro), gnomAD 6-72622196-CG-C, CADD 31.00
- R3H (p.Arg3His), gnomAD 6-72622197-G-A, REVEL 0.49, CADD 25.10
- R3R (p.Arg3Arg), gnomAD 6-72622198-C-T, CADD 16.00
- H4N (p.His4Asn), gnomAD 6-72622199-C-A, REVEL 0.35, CADD 18.40
- H4Y (p.His4Tyr), gnomAD 6-72622199-C-T, REVEL 0.44, CADD 23.30
- H4L (p.His4Leu), gnomAD 6-72622200-A-T, REVEL 0.44, CADD 23.50
- H4R (p.His4Arg), gnomAD 6-72622200-A-G, REVEL 0.40, CADD 21.90
- H4H (p.His4His), gnomAD 6-72622201-C-T, CADD 14.40
- H4Q (p.His4Gln), gnomAD 6-72622201-C-A, REVEL 0.36, CADD 21.00
- H5Q (p.His5Gln), rs2098915503, ClinGen CA364823977, ClinVar RCV003238595, TOPMed rs2098915503, REVEL 0.43, CADD 23.40, Uncertain significance, not provided
- H5R (p.His5Arg), rs2481564953, ClinGen CA364823974, ClinVar RCV003318045, REVEL 0.45, CADD 23.00, Uncertain significance, not provided
- H5Y (p.His5Tyr), TOPMed rs2098915497, REVEL 0.53, CADD 23.70, Uncertain significance, not provided
- H5N (p.His5Asn), gnomAD 6-72622202-C-A, REVEL 0.47, CADD 23.80
- H5H (p.His5His), gnomAD 6-72622204-C-T, CADD 14.40
- A6V (p.Ala6Val), TOPMed rs2098915507, gnomAD rs2098915507, REVEL 0.45, CADD 23.40
- A6P (p.Ala6Pro), gnomAD 6-72622205-G-C, REVEL 0.47, CADD 23.90
- A6S (p.Ala6Ser), gnomAD 6-72622205-G-T, REVEL 0.36, CADD 18.30
- A6T (p.Ala6Thr), gnomAD 6-72622205-G-A, REVEL 0.44, CADD 21.00
- A6E (p.Ala6Glu), gnomAD 6-72622206-C-A, REVEL 0.48, CADD 23.30
- A6A (p.Ala6Ala), gnomAD 6-72622207-G-T, CADD 16.10
- G7R (p.Gly7Arg), rs2154471206, ClinGen CA364823986, ClinVar RCV001878530, Ensembl rs2154471206, REVEL 0.46, CADD 28.00, Uncertain significance, not provided
- G7* (p.Gly7Ter), gnomAD 6-72622208-G-T, CADD 37.00
- G7V (p.Gly7Val), gnomAD 6-72622209-G-T, REVEL 0.48, CADD 27.40
- G7E (p.Gly7Glu), gnomAD 6-72622209-G-A, REVEL 0.46, CADD 28.10
- G7G (p.Gly7Gly), gnomAD 6-72622210-A-G, CADD 16.40
- G8* (p.Gly8Ter), cosmic curated COSV10463, CADD 37.00
- G8E (p.Gly8Glu), rs764586130, ClinGen CA141452100, cosmic curated COSV10520, ClinVar RCV001937237, REVEL 0.34, CADD 23.20, Uncertain significance, not provided
- G8R (p.Gly8Arg), rs191331629, ClinGen CA3886667, ClinVar RCV001252272, ClinVar RCV002069337, REVEL 0.38, CADD 24.70, Benign/Likely benign, Inborn genetic diseases; not provided
- p.Gly8 Glu9insTer, gnomAD 6-72622211-G-GGCT, CADD 33.00
- G8V (p.Gly8Val), gnomAD 6-72622212-G-T, REVEL 0.42, CADD 24.30
- G8G (p.Gly8Gly), gnomAD 6-72622213-A-G, CADD 16.90
- E9D (p.Glu9Asp), Ensembl rs2154471208, REVEL 0.33, CADD 22.60
- E9* (p.Glu9Ter), gnomAD 6-72622214-G-T, CADD 38.00
- E9Q (p.Glu9Gln), gnomAD 6-72622214-G-C, REVEL 0.41, CADD 23.20
- E9G (p.Glu9Gly), gnomAD 6-72622215-A-G, REVEL 0.38, CADD 23.70
- E9E (p.Glu9Glu), gnomAD 6-72622216-G-A, CADD 15.00
- E10D (p.Glu10Asp), cosmic curated COSV10817, REVEL 0.33, CADD 18.00
- E10del (p.Glu10del), gnomAD 6-72622213-AGAG-A, CADD 22.20
- E10K (p.Glu10Lys), gnomAD 6-72622217-G-A, REVEL 0.40, CADD 23.30
- E10V (p.Glu10Val), gnomAD 6-72622218-A-T, REVEL 0.46, CADD 23.60
- E10G (p.Glu10Gly), gnomAD 6-72622218-A-G, REVEL 0.42, CADD 23.40
- E10E (p.Glu10Glu), gnomAD 6-72622219-G-A, CADD 14.20
- G11A (p.Gly11Ala), gnomAD 6-72622218-AG-A, CADD 25.20
- G11C (p.Gly11Cys), gnomAD 6-72622220-G-T, REVEL 0.53, CADD 28.40
- G11D (p.Gly11Asp), gnomAD 6-72622221-G-A, REVEL 0.43, CADD 24.30
- G11G (p.Gly11Gly), gnomAD 6-72622222-C-T, CADD 15.70
- G12A (p.Gly12Ala), rs1013371738, TOPMed rs1013371738, gnomAD rs1013371738, REVEL 0.51, CADD 23.80, Uncertain significance, not provided
- p.Gly12dup, gnomAD 6-72622219-G-GGGC, CADD 22.10
- G12R (p.Gly12Arg), gnomAD 6-72622223-G-C, REVEL 0.48, CADD 24.90
- G12C (p.Gly12Cys), gnomAD 6-72622223-G-T, REVEL 0.56, CADD 28.90
- G12S (p.Gly12Ser), gnomAD 6-72622223-G-A, REVEL 0.45, CADD 24.30
- G12D (p.Gly12Asp), gnomAD 6-72622224-G-A, REVEL 0.54, CADD 24.10
- G12V (p.Gly12Val), gnomAD 6-72622224-G-T, REVEL 0.52, CADD 24.30
- G12G (p.Gly12Gly), gnomAD 6-72622225-C-G, CADD 15.40
- A13S (p.Ala13Ser), TOPMed rs933885701, gnomAD rs933885701, REVEL 0.35, CADD 17.80, Benign
- A13T (p.Ala13Thr), rs933885701, ClinGen CA141452102, ClinVar RCV002601170, ClinVar RCV004782946, REVEL 0.40, CADD 20.90, Conflicting interpretations, not specified; not provided
- A13D (p.Ala13Asp), gnomAD 6-72622227-C-A, REVEL 0.48, CADD 22.50
- A13V (p.Ala13Val), gnomAD 6-72622227-C-T, REVEL 0.47, CADD 22.70
- A13A (p.Ala13Ala), gnomAD 6-72622228-C-T, CADD 16.30
- A14V (p.Ala14Val), rs2098915518, ClinGen CA364824029, ClinVar RCV001999678, ClinVar RCV005406267, REVEL 0.41, CADD 23.60, Uncertain significance, not specified; not provided
- A14T (p.Ala14Thr), gnomAD 6-72622229-G-A, REVEL 0.37, CADD 22.40
- A14S (p.Ala14Ser), gnomAD 6-72622229-G-T, REVEL 0.30, CADD 20.50
- A14D (p.Ala14Asp), gnomAD 6-72622230-C-A, REVEL 0.50, CADD 23.60
- A14A (p.Ala14Ala), rs1049687889, gnomAD 6-72622231-C-G, CADD 15.00
- G15A (p.Gly15Ala), gnomAD rs2098915560, REVEL 0.52, CADD 24.10
- G15R (p.Gly15Arg), rs1245708170, ClinGen CA364824033, ClinVar RCV002810972, TOPMed rs1245708170, REVEL 0.69, CADD 25.90, Uncertain significance, Intellectual disability, autosomal dominant 46
- G15W (p.Gly15Trp), TOPMed rs1245708170, gnomAD rs1245708170, REVEL 0.67, CADD 26.80, Uncertain significance
- G15E (p.Gly15Glu), gnomAD 6-72622233-G-A, REVEL 0.64, CADD 27.80
- G15V (p.Gly15Val), gnomAD 6-72622233-G-T, REVEL 0.70, CADD 27.30
- G15G (p.Gly15Gly), rs889723978, gnomAD 6-72622234-G-T, CADD 14.90
- L16F (p.Leu16Phe), Ensembl rs2098915568, REVEL 0.47, CADD 25.90
- L16S (p.Leu16Ser), gnomAD 6-72622231-CG-C, CADD 25.50
- L16I (p.Leu16Ile), gnomAD 6-72622235-C-A, REVEL 0.39, CADD 23.40
- L16L (p.Leu16Leu), gnomAD 6-72622237-C-A, CADD 13.10
- W17* (p.Trp17Ter), rs1265096046, ClinGen CA364824049, ClinVar RCV003571282, CADD 37.00, Pathogenic
- W17C (p.Trp17Cys), rs1265096046, ClinGen CA364824051, ClinVar RCV002076277, ClinVar RCV004744295, REVEL 0.70, CADD 26.30, Likely benign, not provided
- W17R (p.Trp17Arg), rs971617867, ClinGen CA141452107, ClinVar RCV001199250, ClinVar RCV006557194, REVEL 0.54, CADD 23.90, Uncertain significance, Intellectual disability, autosomal dominant 46; not provided
- W17L (p.Trp17Leu), gnomAD 6-72622239-G-T, REVEL 0.48, CADD 24.70
- W17S (p.Trp17Ser), gnomAD 6-72622239-G-C, REVEL 0.53, CADD 25.10
- V18M (p.Val18Met), gnomAD 6-72622241-G-A, REVEL 0.31, CADD 19.80
- V18L (p.Val18Leu), gnomAD 6-72622241-G-T, REVEL 0.30, CADD 19.90
- V18A (p.Val18Ala), gnomAD 6-72622242-T-C, REVEL 0.40, CADD 23.60
- V18V (p.Val18Val), gnomAD 6-72622243-G-T, CADD 14.70
- K19T (p.Lys19Thr), gnomAD 6-72622245-A-C, REVEL 0.40, CADD 22.90
- K19M (p.Lys19Met), gnomAD 6-72622245-A-T, REVEL 0.38, CADD 23.20
- K19R (p.Lys19Arg), gnomAD 6-72622245-A-G, REVEL 0.35, CADD 20.20
- K19N (p.Lys19Asn), gnomAD 6-72622246-G-T, REVEL 0.35, CADD 22.80
- S20G (p.Ser20Gly), gnomAD rs1000167442, REVEL 0.41, CADD 24.00
- S20C (p.Ser20Cys), gnomAD 6-72622247-A-T, REVEL 0.44, CADD 24.50
- S20I (p.Ser20Ile), gnomAD 6-72622248-G-T, REVEL 0.41, CADD 23.80
- S20R (p.Ser20Arg), gnomAD 6-72622249-C-A, REVEL 0.38, CADD 23.60
- S20S (p.Ser20Ser), rs2154471210, gnomAD 6-72622249-C-T, CADD 15.80
- G21C (p.Gly21Cys), rs1449413875, ClinGen CA364824075, ClinVar RCV001894151, TOPMed rs1449413875, REVEL 0.49, CADD 23.50, Uncertain significance, not provided
- G21R (p.Gly21Arg), TOPMed rs1449413875, gnomAD rs1449413875, REVEL 0.43, CADD 23.20, Uncertain significance
- G21S (p.Gly21Ser), TOPMed rs1449413875, gnomAD rs1449413875, REVEL 0.38, CADD 17.60, Uncertain significance
- G21V (p.Gly21Val), gnomAD 6-72622251-G-T, REVEL 0.43, CADD 23.00
- G21D (p.Gly21Asp), gnomAD 6-72622251-G-A, REVEL 0.44, CADD 22.90
- G21G (p.Gly21Gly), gnomAD 6-72622252-C-A, CADD 13.30
- A22S (p.Ala22Ser), rs553979044, ClinGen CA3886669, ClinVar RCV003664527, 1000Genomes rs553979044, REVEL 0.44, CADD 17.50, Uncertain significance, not provided
- A22T (p.Ala22Thr), cosmic curated COSV59657, REVEL 0.37, CADD 18.90
- A22P (p.Ala22Pro), gnomAD 6-72622253-G-C, REVEL 0.46, CADD 21.00
- A22V (p.Ala22Val), gnomAD 6-72622254-C-T, REVEL 0.39, CADD 21.90
- A22E (p.Ala22Glu), gnomAD 6-72622254-C-A, REVEL 0.45, CADD 21.20
- A22A (p.Ala22Ala), rs1286156412, gnomAD 6-72622255-A-G, CADD 16.20
- A23T (p.Ala23Thr), gnomAD 6-72622256-G-A, REVEL 0.40, CADD 21.90
- A23S (p.Ala23Ser), gnomAD 6-72622256-G-T, REVEL 0.41, CADD 19.80
- A23E (p.Ala23Glu), gnomAD 6-72622257-C-A, REVEL 0.57, CADD 20.20
- A23V (p.Ala23Val), gnomAD 6-72622257-C-T, REVEL 0.44, CADD 20.00
- A23A (p.Ala23Ala), rs1269286659, gnomAD 6-72622258-G-A, CADD 15.40
- A24S (p.Ala24Ser), gnomAD 6-72622259-G-T, REVEL 0.42, CADD 20.20
- A24T (p.Ala24Thr), gnomAD 6-72622259-G-A, REVEL 0.41, CADD 21.60
- A24V (p.Ala24Val), gnomAD 6-72622260-C-T, REVEL 0.38, CADD 18.80
- A24E (p.Ala24Glu), gnomAD 6-72622260-C-A, REVEL 0.55, CADD 19.30
- A24A (p.Ala24Ala), rs1565036578, gnomAD 6-72622261-G-A, CADD 15.70
- A25S (p.Ala25Ser), TOPMed rs1355204350, gnomAD rs1355204350, REVEL 0.45, CADD 20.10
- p.Ala25 Ala27del, rs568022266, gnomAD 6-72622255-AGCGGC, CADD 21.60
- A25K (p.Ala25Lys), gnomAD 6-72622261-G-GAA, CADD 29.90
- A25T (p.Ala25Thr), gnomAD 6-72622262-G-A, REVEL 0.43, CADD 22.40
- A25E (p.Ala25Glu), gnomAD 6-72622263-C-A, REVEL 0.54, CADD 22.00
- A25V (p.Ala25Val), gnomAD 6-72622263-C-T, REVEL 0.46, CADD 22.30
- A25A (p.Ala25Ala), gnomAD 6-72622264-G-A, CADD 15.30
- A26E (p.Ala26Glu), Ensembl rs2154471212, REVEL 0.45, CADD 22.30
- A26T (p.Ala26Thr), rs1464881276, ClinGen CA364824104, ClinVar RCV001871183, ClinVar RCV005652736, REVEL 0.43, CADD 22.50, Conflicting interpretations, Inborn genetic diseases; not provided
- A26V (p.Ala26Val), cosmic curated COSV59678, REVEL 0.40, CADD 19.90
- p.Ala26 Ala27del, gnomAD 6-72622255-AGCGGC, CADD 21.40
- A26G (p.Ala26Gly), gnomAD 6-72622264-GGC-G, CADD 27.50
- A26S (p.Ala26Ser), gnomAD 6-72622265-G-T, REVEL 0.42, CADD 20.30
- A26A (p.Ala26Ala), gnomAD 6-72622267-G-T, CADD 15.00
- A27del (p.Ala27del), gnomAD 6-72622252-CGCA-C, CADD 20.50
- p.Ala27dup, gnomAD 6-72622252-C-CGCA, CADD 19.40
- A27G (p.Ala27Gly), gnomAD 6-72622266-C-CG, CADD 25.10
- A27T (p.Ala27Thr), gnomAD 6-72622268-G-A, REVEL 0.42, CADD 22.40
- A27S (p.Ala27Ser), gnomAD 6-72622268-G-T, REVEL 0.44, CADD 21.30
- A27E (p.Ala27Glu), gnomAD 6-72622269-C-A, REVEL 0.44, CADD 17.10
- A27V (p.Ala27Val), gnomAD 6-72622269-C-T, REVEL 0.43, CADD 20.70
- A27A (p.Ala27Ala), gnomAD 6-72622270-G-T, CADD 15.20
- G28R (p.Gly28Arg), rs2098915594, ClinGen CA364824115, ClinVar RCV002303853, Ensembl rs2098915594, REVEL 0.43, CADD 22.30, Uncertain significance, not provided
- G28V (p.Gly28Val), gnomAD 6-72622260-CGGCGG, CADD 32.00
- G28A (p.Gly28Ala), gnomAD 6-72622269-CG-C, CADD 25.30
- G28S (p.Gly28Ser), gnomAD 6-72622271-G-A, REVEL 0.38, CADD 21.80
- G28C (p.Gly28Cys), gnomAD 6-72622271-G-T, REVEL 0.51, CADD 25.50
- G28D (p.Gly28Asp), gnomAD 6-72622272-G-A, REVEL 0.50, CADD 22.50
- G28G (p.Gly28Gly), rs1434358563, gnomAD 6-72622273-C-A, CADD 15.00
- G29A (p.Gly29Ala), TOPMed rs1321327823
- G29R (p.Gly29Arg), rs952233278, TOPMed rs952233278, gnomAD rs952233278, ClinGen CA141452110, REVEL 0.45, CADD 20.70, Uncertain significance, Inborn genetic diseases
- G29W (p.Gly29Trp), rs952233278, ClinGen CA364824120, ClinVar RCV001815953, TOPMed rs952233278, REVEL 0.48, CADD 23.80, Uncertain significance, not provided
- G29V (p.Gly29Val), gnomAD 6-72622275-G-T, REVEL 0.41, CADD 22.80
- G29E (p.Gly29Glu), gnomAD 6-72622275-G-A, REVEL 0.47, CADD 20.80
- G29G (p.Gly29Gly), rs1258779237, gnomAD 6-72622276-G-C, CADD 15.40
- G30E (p.Gly30Glu), rs756542782, ClinGen CA364824127, ClinVar RCV001902590, ExAC rs756542782, REVEL 0.35, CADD 22.10, Conflicting interpretations, not provided
- G30R (p.Gly30Arg), ExAC rs752456265, TOPMed rs752456265, gnomAD rs752456265, REVEL 0.39, CADD 22.00
- G30V (p.Gly30Val), ExAC rs756542782, TOPMed rs756542782, gnomAD rs756542782, REVEL 0.44, CADD 22.50, Uncertain significance
- G30A (p.Gly30Ala), gnomAD 6-72622266-CGGCG-, CADD 26.20
- G30W (p.Gly30Trp), gnomAD 6-72622277-G-T, REVEL 0.53, CADD 28.70
- G30G (p.Gly30Gly), rs1434168919, gnomAD 6-72622279-G-A, CADD 15.60
- R31C (p.Arg31Cys), 1000Genomes rs2154471215, REVEL 0.58, CADD 25.40
- R31A (p.Arg31Ala), rs1187050062, gnomAD 6-72622273-CG-C, CADD 25.30
- R31G (p.Arg31Gly), gnomAD 6-72622280-C-G, REVEL 0.57, CADD 23.10
- R31S (p.Arg31Ser), gnomAD 6-72622280-C-A, REVEL 0.45, CADD 22.80
- R31H (p.Arg31His), gnomAD 6-72622281-G-A, REVEL 0.44, CADD 22.70
- R31L (p.Arg31Leu), gnomAD 6-72622281-G-T, REVEL 0.53, CADD 22.60
- R31R (p.Arg31Arg), rs2098915612, gnomAD 6-72622282-C-T, CADD 15.60
- L32S (p.Leu32Ser), gnomAD rs2098915614, REVEL 0.50, CADD 11.70
- L32G (p.Leu32Gly), gnomAD 6-72622269-C-CGGG, CADD 25.40
- L32M (p.Leu32Met), gnomAD 6-72622283-T-A, REVEL 0.35, CADD 15.00
- L32V (p.Leu32Val), gnomAD 6-72622283-T-G, REVEL 0.34, CADD 13.30
- L32L (p.Leu32Leu), gnomAD 6-72622283-T-C, CADD 13.20
- L32W (p.Leu32Trp), gnomAD 6-72622284-T-G, REVEL 0.50, CADD 18.80
- L32F (p.Leu32Phe), gnomAD 6-72622285-G-T, REVEL 0.45, CADD 22.70
Public KCNQ5 analysis runs
- KCNQ5 analysis run — KCNQ5 (1,571 variants) — completed 2026-08-20